SMTL ID : 7c3g.1 (1 other biounit)

Crystal structure of human ALK2 kinase domain with R206H mutation in complex with a bicyclic pyrazole inhibitor RK-73134

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x FH0: ~{N}-[4-(4-methylpiperazin-1-yl)phenyl]-4-(2-pyridin-3-yl-6,7-dihydro-4~{H}-pyrazolo[5,1-c][1,4]oxazin-3-yl)pyrimidin-2-amine(Non-covalent)

FH0.1: 18 residues within 4Å: Chain A: V.16, Y.21, V.24, A.35, K.37, L.65, L.83, T.85, H.86, Y.87, H.88, E.89, M.90, G.91, S.92, D.95, K.142, L.145 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:V.16, A:V.24, A:A.35, A:K.37, A:T.85, A:Y.87 Hydrogen bonds: A:H.88 Water bridges: A:S.92, A:S.92, A:D.156, A:D.156

9 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 4 residues within 4Å: Chain A: G.19, R.20, Y.21, K.142 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:R.20 Water bridges: A:R.20, A:Y.21, A:K.140 Salt bridges: A:R.20, A:K.142 SO4.5: 4 residues within 4Å: Chain A: H.86, H.88, K.147, K.148 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:K.148 Water bridges: A:E.89, A:N.149 Salt bridges: A:H.86, A:H.88 SO4.6: 6 residues within 4Å: Chain A: R.20, K.142, R.182, N.239, D.240, P.241 7 PLIP interactions: 7 interactions with chain A Hydrogen bonds: A:D.240, A:D.240 Water bridges: A:R.20, A:R.182 Salt bridges: A:R.20, A:K.142, A:R.182 SO4.7: 2 residues within 4Å: Chain A: Q.165, S.166 No protein-ligand interaction detected (PLIP) SO4.8: 6 residues within 4Å: Chain A: H.122, I.123, K.202, T.289, A.290, L.291 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:A.290, A:L.291 Water bridges: A:D.199 Salt bridges: A:K.202 SO4.9: 2 residues within 4Å: Chain A: D.103, T.104 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:T.104, A:T.104, A:T.104 Water bridges: A:V.105 SO4.10: 2 residues within 4Å: Chain A: F.126, S.166 2 PLIP interactions: 2 interactions with chain A Water bridges: A:E.124, A:S.164 SO4.11: 6 residues within 4Å: Chain A: Y.96, T.100, T.101, L.102, D.103, S.106 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:Y.96, A:T.100, A:D.103, A:S.106, A:S.106 SO4.12: 2 residues within 4Å: Chain A: V.105, R.109 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:R.109

2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.3: 6 residues within 4Å: Chain A: F.233, D.235, V.236, Q.255, R.256, N.258 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:Q.255, A:N.258 Water bridges: A:F.233, A:N.258, A:N.258 EDO.4: 2 residues within 4Å: Chain A: K.45, N.174 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:K.45, A:N.174

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Yamamoto, H. et al., Novel bicyclic pyrazoles as potent ALK2 (R206H) inhibitors for the treatment of fibrodysplasia ossificans progressiva. Bioorg.Med.Chem.Lett. (2021)

Release Date

2021-03-03

Peptides

Activin receptor type-1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Activin receptor type-1

Related Entries With Identical Sequence